Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LABNASDAQ:PRENYSE:SENSNASDAQ:TER On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABStandard BioTools$1.20+8.1%$1.14$0.97▼$2.74$454.78M1.542.19 million shs785,935 shsPREPrenetics Global$5.27+0.8%$4.33$3.09▼$6.99$64.32M-0.217,284 shs6,333 shsSENSSenseonics$0.71-1.8%$0.67$0.25▼$1.40$464.49M0.846.34 million shs4.24 million shsTERTeradyne$75.88+2.8%$84.28$65.77▼$163.21$12.20B1.652.57 million shs2.53 million shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABStandard BioTools+8.11%+3.45%+1.69%-22.58%-52.76%PREPrenetics Global-0.94%+4.29%+34.10%-1.22%+7.33%SENSSenseonics-1.81%-5.99%+8.46%-26.10%+53.51%TERTeradyne+2.85%-1.61%-9.26%-34.47%-33.29%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLABStandard BioTools2.5546 of 5 stars3.33.00.00.00.64.20.6PREPrenetics Global1.9519 of 5 stars3.53.00.00.00.60.01.3SENSSenseonics1.8034 of 5 stars3.80.00.00.01.90.00.6TERTeradyne4.9483 of 5 stars4.33.01.73.43.82.52.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLABStandard BioTools 2.50Moderate Buy$2.50108.33% UpsidePREPrenetics Global 3.00Buy$9.0070.78% UpsideSENSSenseonics 3.50Strong Buy$2.00181.69% UpsideTERTeradyne 2.65Moderate Buy$117.5654.93% UpsideCurrent Analyst Ratings BreakdownLatest TER, LAB, PRE, and SENS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/30/2025TERTeradyneSusquehannaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetPositive ➝ Positive$155.00 ➝ $133.004/17/2025TERTeradyneJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$120.00 ➝ $92.004/17/2025TERTeradyneKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Sector Weight4/16/2025TERTeradyneMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$81.00 ➝ $69.004/10/2025SENSSenseonicsMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$2.004/9/2025SENSSenseonicsMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy3/14/2025TERTeradyneMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$112.00 ➝ $81.003/13/2025TERTeradyneRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$140.00 ➝ $110.003/12/2025TERTeradyneUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$155.00 ➝ $130.003/12/2025TERTeradyneCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$130.00 ➝ $100.003/12/2025TERTeradyneSusquehannaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetPositive ➝ Positive$165.00 ➝ $155.00(Data available from 5/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLABStandard BioTools$174.43M2.61N/AN/A($1.85) per share-0.65PREPrenetics Global$25.56M2.52N/AN/A$17.22 per share0.31SENSSenseonics$22.47M20.67N/AN/A$0.07 per share10.14TERTeradyne$2.82B4.33$2.53 per share29.94$17.31 per share4.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLABStandard BioTools-$74.66M-$0.55N/AN/AN/A-79.92%-27.05%-15.52%5/6/2025 (Estimated)PREPrenetics Global-$62.72M-$3.99N/AN/AN/A-191.73%-16.45%-13.34%6/17/2025 (Estimated)SENSSenseonics-$60.39M-$0.12N/AN/AN/A-362.30%-842.25%-67.99%N/ATERTeradyne$542.37M$3.5422.7914.882.8319.23%19.08%14.47%N/ALatest TER, LAB, PRE, and SENS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025LABStandard BioTools-$0.04N/AN/AN/A$40.10 millionN/A4/28/2025Q1 2025TERTeradyne$0.61$0.75+$0.14$0.60$680.54 million$685.70 million3/3/2025Q4 2024SENSSenseonics-$0.03-$0.12-$0.09N/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLABStandard BioToolsN/AN/AN/AN/AN/APREPrenetics Global$2.8053.13%N/AN/A N/ASENSSenseonicsN/AN/AN/AN/AN/ATERTeradyne$0.480.63%+6.27%13.56%1 YearsCompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLABStandard BioToolsN/A3.763.41PREPrenetics GlobalN/A1.401.22SENSSenseonics59.172.472.38TERTeradyneN/A2.912.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLABStandard BioTools53.74%PREPrenetics Global25.01%SENSSenseonics12.36%TERTeradyne99.77%Insider OwnershipCompanyInsider OwnershipLABStandard BioTools53.10%PREPrenetics Global7.80%SENSSenseonics3.60%TERTeradyne0.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLABStandard BioTools620378.99 million174.59 millionOptionablePREPrenetics Global112.21 million11.25 millionNot OptionableSENSSenseonics90654.22 million573.90 millionN/ATERTeradyne6,500160.83 million162.28 millionOptionableTER, LAB, PRE, and SENS HeadlinesRecent News About These CompaniesQ2 Earnings Estimate for Teradyne Issued By Northland CapmkMay 3 at 7:12 AM | marketbeat.comNorthland Capmk Has Pessimistic View of Teradyne Q3 EarningsMay 3 at 3:25 AM | americanbankingnews.comEquities Analysts Set Expectations for Teradyne Q2 EarningsMay 3 at 2:35 AM | americanbankingnews.comTeradyne, Inc. (NASDAQ:TER) Just Reported, And Analysts Assigned A US$104 Price TargetMay 2 at 3:14 PM | finance.yahoo.comTeradyne, Inc. (NASDAQ:TER) Sees Significant Increase in Short InterestMay 2 at 10:26 AM | marketbeat.comTeradyne (NASDAQ:TER) Hits New 1-Year Low Following Analyst DowngradeMay 2 at 2:47 AM | americanbankingnews.comTraders Purchase High Volume of Teradyne Put Options (NASDAQ:TER)May 1 at 12:18 PM | marketbeat.comTeradyne, Inc. (NASDAQ:TER) Stock Holdings Lifted by Schonfeld Strategic Advisors LLCMay 1 at 8:19 AM | marketbeat.comPaloma Partners Management Co Has $10.39 Million Holdings in Teradyne, Inc. (NASDAQ:TER)May 1 at 8:11 AM | marketbeat.comPrice T Rowe Associates Inc. MD Has $55.23 Million Stock Holdings in Teradyne, Inc. (NASDAQ:TER)May 1 at 5:11 AM | marketbeat.comKLA's Earnings: A PreviewApril 30 at 11:59 PM | benzinga.comStock Repurchase Plan Declared by Teradyne (NASDAQ:TER) April 30 at 10:04 PM | marketbeat.comTeradyne, Inc. (TER): Among the Worst Performing Stocks in S&P 500 So Far in 2025April 30 at 8:17 PM | insidermonkey.comTeradyne (NASDAQ:TER) Issues Q2 2025 Earnings GuidanceApril 30 at 7:17 PM | marketbeat.comTeradyne (NASDAQ:TER) Releases Quarterly Earnings Results, Beats Expectations By $0.14 EPSApril 30 at 6:11 PM | marketbeat.comVoya Investment Management LLC Has $13.79 Million Stock Position in Teradyne, Inc. (NASDAQ:TER)April 30 at 5:39 AM | marketbeat.comQ1 2025 Teradyne Inc Earnings CallApril 30 at 2:59 AM | finance.yahoo.comTraders Buy Large Volume of Put Options on Teradyne (NASDAQ:TER)April 30 at 2:13 AM | americanbankingnews.comShare Buyback Program Initiated by Teradyne (NASDAQ:TER) April 30 at 1:21 AM | americanbankingnews.comTeradyne Boosts 1Q Sales With Semiconductor TestingApril 29, 2025 | marketwatch.comTeradyne (NasdaqGS:TER) Stock Jumps 10% Over Last WeekApril 29, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAre Short Sellers Wrong About These 3 Semiconductor Stocks?By Leo Miller | April 4, 2025View Are Short Sellers Wrong About These 3 Semiconductor Stocks?Why D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumBroadcom's VMware Deal Lifts AVGO Despite Complaints By Leo Miller | April 28, 2025View Broadcom's VMware Deal Lifts AVGO Despite Complaints Joby Aviation Shares Eye Breakout After Transition Flight WinBy Jeffrey Neal Johnson | April 30, 2025View Joby Aviation Shares Eye Breakout After Transition Flight WinNewsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?By Jeffrey Neal Johnson | April 6, 2025View Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?TER, LAB, PRE, and SENS Company DescriptionsStandard BioTools NASDAQ:LAB$1.20 +0.09 (+8.11%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$1.20 0.00 (-0.42%) As of 05/2/2025 06:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.Prenetics Global NASDAQ:PRE$5.32 +0.10 (+1.82%) As of 05/2/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.Senseonics NYSE:SENS$0.71 -0.01 (-1.81%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$0.71 +0.00 (+0.14%) As of 05/2/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.Teradyne NASDAQ:TER$75.88 +2.10 (+2.85%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$75.95 +0.07 (+0.09%) As of 05/2/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Teradyne, Inc. designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications. This segment also provides FLEX test platform systems; J750 test system to address the volume semiconductor devices, including microcontrollers; Magnum platform that tests memory devices, such as flash memory and DRAM; and ETS platform for semiconductor manufacturers, and assembly and test subcontractors in the analog/mixed signal markets. It serves integrated device manufacturers that integrate the fabrication of silicon wafers into their business; fabless companies that outsource the manufacturing of silicon wafers; foundries; and semiconductor assembly and test providers. The System Test segment offers defense/aerospace test instrumentation and systems; storage and system level test systems; and circuit-board test and inspection systems. The Wireless Test segment provides wireless test solutions for silicon validation, wireless module manufacturing, and wireless end device manufacturing under the LitePoint brand. This segment also offers IQxel-MX and IQxel-MW7G series products for edge measurement performance in the manufacturing of connectivity products; IQxstream-5G and IQgig-5G family products to support 4G and 5G technologies; and IQgig-UWB+ for certification and manufacturing test support for ultra wideband products. The Robotics segment provides collaborative robotic arms, autonomous mobile robots, and advanced robotic control software for manufacturing, logistics, and industrial customers. The company was incorporated in 1960 and is headquartered in North Reading, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/28 - 05/02 Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious Meta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 Why Spotify Stock Still Has Room to Run in 2025 Is It Time to Load Up on Bond ETFs? Palantir Earnings: 1 Bullish Signal and 1 Area of Concern Roblox Stock Gains Momentum and Can Top $100 in 2025 Visa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
